Publicacións nas que colabora con Javier García Seara (80)
2024
-
Impact of initiation of SGLT2 inhibitor treatment on the development of arrhythmias in patients with implantable cardiac devices
Revista Espanola de Cardiologia, Vol. 77, Núm. 6, pp. 481-489
-
Prognostic value of the tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio in cardiac amyloidosis
Revista Espanola de Cardiologia
-
Pseudotransposition of the great leads
PACE - Pacing and Clinical Electrophysiology, Vol. 47, Núm. 2, pp. 233-235
2023
-
Atrial fibrillation ablation in patients with arrhythmia-induced cardiomyopathy: a prospective multicentre study
ESC Heart Failure, Vol. 10, Núm. 5, pp. 3055-3066
-
Circulating miR-451a Expression May Predict Recurrence in Atrial Fibrillation Patients after Catheter Pulmonary Vein Ablation
Cells, Vol. 12, Núm. 4
-
Clinical and cost-effectiveness results of an on-call program for pacemaker implantations
Revista Espanola de Cardiologia, Vol. 76, Núm. 11, pp. 936-937
-
Plasma miR-486-5p Expression Is Upregulated in Atrial Fibrillation Patients with Broader Low-Voltage Areas
International Journal of Molecular Sciences, Vol. 24, Núm. 20
-
Role of Soluble ST2 Biomarker in Predicting Recurrence of Atrial Fibrillation after Electrical Cardioversion or Pulmonary Vein Isolation
International Journal of Molecular Sciences, Vol. 24, Núm. 18
-
The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats
Biomedicine and Pharmacotherapy, Vol. 161
2022
-
Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry
European Journal of Internal Medicine, Vol. 99, pp. 45-56
-
Circulating miR-499a and miR-125b as Potential Predictors of Left Ventricular Ejection Fraction Improvement after Cardiac Resynchronization Therapy
Cells, Vol. 11, Núm. 2
-
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry
BMC Medicine, Vol. 20, Núm. 1
-
Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry
Europace, Vol. 24, Núm. 5, pp. 721-728
-
Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry
European Journal of Clinical Investigation, Vol. 52, Núm. 7
-
Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry
European Journal of Clinical Investigation, Vol. 52, Núm. 6
-
Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers
Scientific Reports, Vol. 12, Núm. 1
-
The Role of Fatty Acid-Binding Protein 4 in the Characterization of Atrial Fibrillation and the Prediction of Outcomes after Catheter Ablation
International Journal of Molecular Sciences, Vol. 23, Núm. 19
2021
-
Conventional single-chamber pacemakers versus transcatheter pacing systems in a “real world” cohort of patients: A comparative prospective single-center study
Indian Pacing and Electrophysiology Journal, Vol. 21, Núm. 2, pp. 89-94
-
Correction to: Galectin-3 and soluble RAGE as new biomarkers of post-infarction cardiac remodeling (Journal of Molecular Medicine, (2021), 99, 7, (943-953), 10.1007/s00109-021-02054-6)
Journal of Molecular Medicine
-
Differences in the clinical profile and management of atrial fibrillation according to gender. Results of the registro gallego intercéntrico de fibrilación auricular (regueifa) trial
Journal of Clinical Medicine, Vol. 10, Núm. 17